Recent events
Every US listed company has to file a Form 8-K within four business days of something significant happening, and tag it with the item number that says what kind of thing it was. This is that feed, over the last 180 days - the filings themselves, on EDGAR, one click away. Nothing here is a summary of what a filing said; it is what the company told SEC it was filing about.
Every 8-K item filed, including the routine ones - earnings dates, shareholder votes and Regulation FD disclosures. Not the exhibit lists.
| Date | Company | Event | Filing |
|---|---|---|---|
| UWM Holdings Corp UWMC | Unregistered share sale Item 3.02 | Form 8-K | |
| UWM Holdings Corp UWMC | Officer or director change Item 5.02 | Form 8-K | |
| UWM Holdings Corp UWMC | Charter or fiscal year changed Item 5.03 | Form 8-K | |
| UWM Holdings Corp UWMC | Other event Item 8.01 | Form 8-K | |
| Ultra Clean Holdings, Inc. UCTT | Officer or director change Item 5.02 | Form 8-K | |
| Unity Software Inc. U | Results announced Item 2.02 | Form 8-K | |
| Unusual Machines, Inc. UMAC | Results announced Item 2.02 | Form 8-K | |
| Unusual Machines, Inc. UMAC | Regulation FD disclosure Item 7.01 | Form 8-K | |
| Urban Edge Properties UE | Results announced Item 2.02 | Form 8-K | |
| Urban Edge Properties UE | Regulation FD disclosure Item 7.01 | Form 8-K | |
| VAALCO ENERGY INC /DE/ EGY | Results announced Item 2.02 | Form 8-K | |
| VAALCO ENERGY INC /DE/ EGY | Regulation FD disclosure Item 7.01 | Form 8-K | |
| VALHI INC /DE/ VHI | Results announced Item 2.02 | Form 8-K | |
| VALHI INC /DE/ VHI | Regulation FD disclosure Item 7.01 | Form 8-K | |
| VICI PROPERTIES INC. VICI | Material agreement signed Item 1.01 | Form 8-K | |
| VICI PROPERTIES INC. VICI | Other event Item 8.01 | Form 8-K | |
| VIVMARK RESIDENTIAL VMRK | Other event Item 8.01 | Form 8-K | |
| VSE CORP VSEC | Other event Item 8.01 | Form 8-K | |
| Valion Bio, Inc. VBIO | Material agreement signed Item 1.01 | Form 8-K | |
| Valion Bio, Inc. VBIO | Unregistered share sale Item 3.02 | Form 8-K | |
| Valion Bio, Inc. VBIO | Other event Item 8.01 | Form 8-K | |
| Verastem, Inc. VSTM | Results announced Item 2.02 | Form 8-K | |
| Verrica Pharmaceuticals Inc. VRCA | Results announced Item 2.02 | Form 8-K | |
| Versant Media Group, Inc. VSNT | Results announced Item 2.02 | Form 8-K | |
| Versant Media Group, Inc. VSNT | Regulation FD disclosure Item 7.01 | Form 8-K | |
| Via Transportation, Inc. VIA | Results announced Item 2.02 | Form 8-K | |
| Viatris Inc VTRS | Results announced Item 2.02 | Form 8-K | |
| Viatris Inc VTRS | Other event Item 8.01 | Form 8-K | |
| Viridian Therapeutics, Inc.\DE VRDN | Results announced Item 2.02 | Form 8-K | |
| Virtuix Holdings Inc. VTIX | Auditor changed Item 4.01 | Form 8-K | |
| Vistagen Therapeutics, Inc. VTGN | Regulation FD disclosure Item 7.01 | Form 8-K | |
| Vistagen Therapeutics, Inc. VTGN | Other event Item 8.01 | Form 8-K | |
| Vistance Networks, Inc. VISN | Results announced Item 2.02 | Form 8-K | |
| Vistance Networks, Inc. VISN | Officer or director change Item 5.02 | Form 8-K | |
| Vistance Networks, Inc. VISN | Other event Item 8.01 | Form 8-K | |
| Vital Farms, Inc. VITL | Material agreement signed Item 1.01 | Form 8-K | |
| Vital Farms, Inc. VITL | Material agreement terminated Item 1.02 | Form 8-K | |
| Vital Farms, Inc. VITL | Results announced Item 2.02 | Form 8-K | |
| Vital Farms, Inc. VITL | New debt or obligation Item 2.03 | Form 8-K | |
| Vital Farms, Inc. VITL | Other event Item 8.01 | Form 8-K |
Item numbers are Form 8-K's own. An 8-K says that a company filed about something, not what it decided - a management change under item 5.02 covers both a routine board retirement and a chief executive being removed, and only the filing tells you which. Dates are filing dates: an 8-K is due within four business days of the event, so the event itself is up to a week earlier. Events are collected from each company's SEC submissions index, which reaches back roughly a thousand filings - for a company that files often, that is less than three years.